![](/img/cover-not-exists.png)
PCN51 HEALTH CARE COSTS ASSOCIATED WITH ANGIOGENESIS INHIBITORS (AIS) AND MTOR INHIBITORS (MTORS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) TREATED AT US COMMUNITY ONCOLOGY CLINICS
K Chen, SP Sarda, L Antràs, S Whittemore, A Luka, P Ramamurthy, J Scott, B Fortner, MP Neary, MS Duh, P JollyVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72140-9
File:
PDF, 81 KB
english, 2010